BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 205 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2019. The put-call ratio across all filers is 1.21 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,758 | -20.5% | 35 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $2,212 | +40.4% | 35 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $1,575 | -29.5% | 35 | -31.4% | 0.00% | 0.0% |
Q4 2022 | $2,234 | -25.5% | 51 | 0.0% | 0.00% | -50.0% |
Q3 2022 | $3,000 | 0.0% | 51 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $3,000 | -40.0% | 51 | 0.0% | 0.00% | -33.3% |
Q4 2021 | $5,000 | -28.6% | 51 | -29.2% | 0.00% | -25.0% |
Q3 2021 | $7,000 | +16.7% | 72 | 0.0% | 0.00% | +33.3% |
Q2 2021 | $6,000 | -14.3% | 72 | 0.0% | 0.00% | -25.0% |
Q1 2021 | $7,000 | +16.7% | 72 | +30.9% | 0.00% | 0.0% |
Q4 2020 | $6,000 | +50.0% | 55 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $4,000 | -42.9% | 55 | -42.7% | 0.00% | -20.0% |
Q3 2019 | $7,000 | -30.0% | 96 | -8.6% | 0.01% | -28.6% |
Q2 2019 | $10,000 | +25.0% | 105 | 0.0% | 0.01% | +16.7% |
Q1 2019 | $8,000 | -11.1% | 105 | -5.4% | 0.01% | +50.0% |
Q3 2018 | $9,000 | – | 111 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 878,875 | $70,354,000 | 45.87% |
CVI Holdings, LLC | 200,000 | $16,010,000 | 15.16% |
Foresite Capital Management III, LLC | 467,682 | $37,438,000 | 9.74% |
Casdin Capital, LLC | 848,648 | $67,934,000 | 7.46% |
BVF INC/IL | 564,965 | $45,225,000 | 5.06% |
Ghost Tree Capital, LLC | 240,000 | $19,212,000 | 5.02% |
DAFNA Capital Management LLC | 119,718 | $9,583,000 | 4.13% |
HHLR ADVISORS, LTD. | 1,498,516 | $119,956,000 | 3.34% |
Opaleye Management Inc. | 130,000 | $10,407,000 | 2.88% |
Perceptive Advisors | 1,271,054 | $101,748,000 | 2.87% |